Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
for
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05092373
Phase1, Recruiting
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
for
Large Cell Neuroendocrine Carcinoma,
Location: Princeton NJ, Glen Burnie MD, Cleveland OH, Atlanta GA,
Sponsor: Molecular Partners AG
Sex: All
Age: 18+
Code: NCT07278479
Phase1, Phase2, Recruiting
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
for
Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer,
Location: Baltimore MD, Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT05312671
Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for
Metastatic Non-small Cell Lung Cancer
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06417814
Phase3, Recruiting
Repositioning Immunotherapy in VetArans With Lung Cancer
for
Non-Small Cell Lung Cancer
Location: West Haven CT, Washington D.C. DC, Richmond VA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06275360
Phase2, Recruiting
Interested in new pancreatic cancer trials?
Get alerts for new trials in your area by subscribing now
Mosaic Trial for Stem Cell Transplant Recipients
for
Hematologic Malignancy, Stem Cell Transplant,
Location: Nutley NJ, Washington D.C. DC, Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06960993
Recruiting
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT05542407
Phase1, Recruiting
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 0 - 70+
Code: NCT00001160
Recruiting
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
for
Advanced Esophageal Squamous Cell Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06265285
Phase2, Recruiting
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
for
Lung Cancer, Lung Cancer Metastatic, Brain Metastases,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05419076
Phase2, Recruiting
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: New York NY, Glen Burnie MD, Miami FL, Pittsburgh PA,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT05477576
Phase3, Recruiting
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
for
Lung Non-Small Cell Carcinoma, Stage IB Lung Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06918132
Phase2, Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for
Carcinoma, Non-Small Cell Lung,
Location: Boston MA, Newton MA, Shirley NY, Riverhead NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04389632
Phase1, Recruiting
A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T
for
Large B-cell Lymphoma
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT06167785
Phase2, Recruiting
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma